BCTXZ NASDAQ
BriaCell Therapeutics Corp. Warrant
1W: +86.7%
1M: +55.1%
3M: +222.2%
YTD: +18.4%
1Y: +39.8%
$0.30
+0.14 (+83.95%)
Weekly Expected Move ±49.4%
$0
$0
$0
$0
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Cash Flow Trends
Operating Cash Flow
-$28M
-16.8% ▼
Capital Expenditures
$3
+100.0% ▲
Free Cash Flow
-$28M
-14.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$10M
+147.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$14M | -$27M | -$20M | -$5M | -$27M |
| Depreciation & Amort. | $15K | $15K | $15K | $84K | $107K |
| Stock-Based Comp. | $2M | $3M | $2M | $2M | $777K |
| Change in Working Capital | -$2M | -$391K | -$4M | $7M | -$3M |
| Other Non-Cash Items | $6M | $12M | -$2M | -$28M | $162K |
| Operating Cash Flow | -$8M | -$12M | -$24M | -$24M | -$28M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | -$457K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | -$225K | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | -$7M |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | -$330K |
| Investing Cash Flow | $0 | $0 | $0 | -$682K | -$8M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$330K | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | -$10M | -$47K | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $14M | $6M | $2K | $0 | -$18M |
| Financing Cash Flow | $65M | -$4M | $4M | $4M | $45M |
| Net Change in Cash | $57M | -$16M | -$20M | -$20M | $10M |
| Cash End of Period | $57M | $41M | $21M | $862K | $10M |
| Free Cash Flow | -$8M | -$12M | -$24M | -$25M | -$28M |